David J. Marguglio's Insider Trades & SAST Disclosures
David J. Marguglio's most recent trade in DMK Pharmaceuticals Corp was a trade of 11,859 Common Stock done at an average price of $0.6 . Disclosure was reported to the exchange on March 18, 2022.
Add Superstar Alert
Share
Note
This is a custom search result for pattern David J. Marguglio.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| DMK Pharmaceuticals Corp | David J. Marguglio | Director, SVP and Chief Business Officer | Sale of securities on an exchange or to another person at price $ 0.60 per share. | 18 Mar 2022 | 11,859 | 233,906 (0%) | 0% | 0.6 | 7,117 | Common Stock |
| DMK Pharmaceuticals Corp | David J. Marguglio | Director, SVP and Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Feb 2021 | 22,258 | 309,522 (0%) | 0% | - | Common Stock | |
| DMK Pharmaceuticals Corp | David J. Marguglio | Director, SVP and Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Feb 2021 | 22,258 | 0 | - | - | Restricted Stock Units | |
| DMK Pharmaceuticals Corp | David J. Marguglio | Director, SVP and Chief Business Officer | Sale of securities on an exchange or to another person at price $ 0.40 per share. | 20 Nov 2020 | 35,000 | 287,264 (0%) | 0% | 0.4 | 14,000 | Common Stock |
| DMK Pharmaceuticals Corp | David J. Marguglio | Director, SVP and Chief Business Officer | Sale of securities on an exchange or to another person at price $ 0.41 per share. | 18 Nov 2020 | 8,532 | 322,264 (0%) | 0% | 0.4 | 3,465 | Common Stock |
| DMK Pharmaceuticals Corp | David J. Marguglio | Director, SVP and Chief Business Officer | Sale of securities on an exchange or to another person at price $ 0.80 per share. | 29 Sep 2020 | 20,000 | 308,539 (0%) | 0% | 0.8 | 16,000 | Common Stock |
| DMK Pharmaceuticals Corp | David J. Marguglio | Director, SVP and Chief Business Officer | Sale of securities on an exchange or to another person at price $ 0.87 per share. | 18 Aug 2020 | 8,749 | 328,539 (0%) | 0% | 0.9 | 7,648 | Common Stock |
| DMK Pharmaceuticals Corp | David J. Marguglio | Director, SVP and Chief Business Officer | Sale of securities on an exchange or to another person at price $ 0.56 per share. | 18 May 2020 | 7,734 | 337,288 (0%) | 0% | 0.6 | 4,332 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges